XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,751 | +28.1% | 3,887 | +44.4% | 0.00% | – |
| Q2 2023 | $103,591 | +324.5% | 2,691 | +294.6% | 0.00% | – |
| Q1 2023 | $24,402 | -9.6% | 682 | +0.9% | 0.00% | – |
| Q4 2022 | $27,000 | +22.7% | 676 | +14.4% | 0.00% | – |
| Q3 2022 | $22,000 | +175.0% | 591 | +124.7% | 0.00% | – |
| Q2 2022 | $8,000 | +166.7% | 263 | +163.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 100 | -73.3% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 375 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -46.2% | 375 | -50.0% | 0.00% | – |
| Q1 2021 | $13,000 | +8.3% | 750 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +50.0% | 750 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 750 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |